Novel chalcones as Bcl-2 inhibitor in lung cancer: docking, design and synthesis of 2,3-Tetrasubstituted-2,3-dihydrobenzofuran-3-carboxamides
Crossref DOI link: https://doi.org/10.1007/s12039-020-01812-2
Published Online: 2020-08-11
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dey, Sankar P
Sepay, Nayim
Mallik, Asok K
Patra, Amarendra
Text and Data Mining valid from 2020-08-11
Version of Record valid from 2020-08-11
Article History
Received: 19 January 2020
Revised: 10 May 2020
Accepted: 13 June 2020
First Online: 11 August 2020